The USDA has created an unequal marketplace for domestic hemp producers, unfounded safety concerns about the use of industrial hemp and bolstered an international agricultural industry at the cost of one in their home country.

Considered dangerous drugs by the federal government, marijuana and industrial hemp are still listed in the Controlled Substances Act as Schedule I drugs.

While the federal government has issued legislative promises to not spend money in prosecution of cannabis activity in states in which it is legal, it has been firm in withholding any actions of endorsement by federal departments, leading many to assume that an organic certification from the U.S. Department of Agriculture is precluded by federal law.

Click here to read the complete article

Sarah Haas ~ Boulder Weekly ~

Recent News Articles

Monday October 21

Key Northeastern governors join forces to chart a path to legalizing marijuana - Cannabis News

in Top Stories

by Bruce Kennedy - Editor in Chief

The governors of Pennsylvania, New Jersey, Connecticut, and New York met Thursday for a summit…

987 hits

Monday October 21

UConn Launches Hemp Testing Lab in Response to Industry Need - Cannabis News

in Science

by Bruce Kennedy - Editor in Chief

In response to a rapidly expanding commercial hemp industry driven by interest in products with…

1017 hits

Monday October 21

Slow rollout in marijuana sales costs Maine revenue and jobs - Cannabis News

in Finance

by Bruce Kennedy - Editor in Chief

Three years after legalizing adult-use marijuana, the state’s still waiting for retail shops. Consultants say…

979 hits

Monday October 21

Chesapeake Bay scientists studying environmental, economic uses for hemp - Cannabis News

in Cannabis News

by Bruce Kennedy - Editor in Chief

A Gold Rush mentality has erupted across Chesapeake Bay states as the lacy fan-shaped leaves…

1466 hits

Tuesday October 22

Michael J. Fox Parkinson’s Foundation Urges Congress To Pass Three Marijuana Research Bills - Cannabis…

in Activism

by Bruce Kennedy - Editor in Chief

A leading advocacy group that’s dedicated to finding treatment options for Parkinson’s disease is backing…

834 hits